Founded with a mission to revolutionize cardiovascular health, Avicena develops advanced medical devices and algorithms designed to easily assess cardiovascular conditions. Their flagship product, Vivio®, offers a mobile, non-invasive approach to diagnosing cardiovascular diseases, making it accessible across various care settings. Avicena aims to improve patient outcomes through rapid and accurate health assessments, targeting both healthcare providers and patients in need of efficient cardiovascular diagnostics.
Avicena has attracted notable investors and affiliations within the medical technology sector, bolstering its credibility and reach. The company has achieved significant milestones, including the successful deployment of Vivio® in multiple healthcare environments, demonstrating its practical utility and effectiveness. Through its innovative solutions, Avicena is making a substantial impact on the early detection and management of cardiovascular diseases, contributing to better health outcomes on a global scale.
